Preliminary efficacy of bevacizumab with first-line FOLFOX, XELOX, FOLFIRI and monotherapy for mCRC: First BEATrial. - Kretzschmar,A.; Van Custem,E.; Michael,M. (J Clin Oncol, 2007)